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Abstract
Background: Despite a significant decrease in maternal mortality in the last decade, Rwanda needs further
progress in order to achieve Sustainable Development Goals (SDG)3 which addresses among others maternal
mortality. Analysis of severe maternal outcomes (SMO) was performed to identify their characteristics, causes
and contributory factors, using standard indicators for quality of care.
Methods: A prospective case-control study was conducted for which data were collected between November
2015 and April 2016 in four rural district hospitals. The occurrence of SMO with near miss incidence ratios was
established, followed by an analysis of the characteristics, clinical outcomes, causes and contributory factors.
Results: The SMO incidence ratio was 38.4 per 1000 live births (95% CI 33.4–43.4) and the maternal near-miss
incidence ratio was 36 per 1000 live births (95% CI 31.1–40.9). The leading causes of SMO were postpartum
haemorrhage (23.4%), uterine rupture (22.9%), abortion related complications (16.8%), malaria (13.6%) and
hypertensive disorders (8.9%). The case fatality rate was high for women with hypertensive disorders (10.5%;
CI 3.3–24.3) and severe postpartum haemorrhage (8%; CI 0.5–15.5). Stillbirth (OR = 181.7; CI 43.5–757.9) and
length of stay at the hospital (OR = 7.9; CI 4.5–13.8) were strongly associated with severe outcomes.
Conclusions: Despite the use of life saving interventions, SMO are frequent. Mortality index was found to be low at
the level of district hospitals. SMO were associated with long stay at the hospital and stillbirth. There is a need for
improvement of quality of care, referral practices and certain types of infrastructure, especially blood banks, which
would ensure truly comprehensive emergency obstetric care and reduce the occurrence of SMO.
Keywords: Severe maternal outcome, Maternal near miss, Obstetrics, Quality of care
Background
Globally, the Maternal Mortality Ratio (MMR) has fallen
by nearly 44% over the past 25 years, to an estimated 216
maternal deaths per 100,000 live births in 2015. Despite
this global decline, the magnitude of the reduction differed
substantially between regions, with low and middle-
income countries accounting for approximately 99% of
global maternal deaths and sub-Saharan Africa alone
accounting for roughly 66% [1]. Rwanda is one of only
four countries that have achieved the Millennium
Development Goals 4 and 5 (MDGs 4 and 5) [2].
According to the Rwanda Demographic Health Survey
(RDHS) 2014–2015, the MMR decreased from 1071 in
2000 to 210 in 2015, while the percentage of institutional
deliveries increased from 27% to 91% over the same
period [3, 4]. However, a fast increase of deliveries in
health facilities may compromise the quality of care that
mothers receive, especially in primary care facilities [5].
The Sustainable Development Goals (SDGs) now call
for an acceleration of progress in order to achieve a global
MMR of 70 maternal deaths per 100,000 live births or less
by 2030 [1]. Rwanda has demonstrated a strong political
will to improve maternal and newborn health. One of the
measures taken to achieve this was the introduction in
2009 of maternal death audits (MDA) on a routine basis
nationwide [6]. However, since maternal mortality reveals
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only the tip of the iceberg, several countries have initiated
maternal near-miss audits [7]. Rwanda might be able to
further improve its performance by reviewing the circum-
stances that led to maternal near miss events where the
women survived. By evaluating such cases much can be
learnt about the processes in place and systemic deficien-
cies that cause failure to deal with maternal morbidities.
For this purpose WHO recommends the near-miss
approach for maternal health [8].
Few studies have been done on maternal near-miss in
Rwanda. They were conducted in tertiary hospitals situ-
ated in Kigali [9–11], or in provincial referral hospitals
that are better equipped than district hospitals in terms
of infrastructure (e.g. intensive care units, ICU) and hu-
man resources [12]. District hospitals in Rwanda nor-
mally handle only cases that are referred by health
centres, because of high-risk pregnancy or the occur-
rence of complications. Approximately 80% of all deliv-
eries occur at the level of health centres [13]. Due to
this risk selection system, near-miss data from tertiary
or provincial hospitals do not reflect common practice
at lower level health facilities. In addition, most studies
on maternal near-miss are descriptive, based on case
series. We conducted a multicentre, case-control study
of severe maternal outcome (SMO) and women without
SMO at district hospital level. Apart from the health
outcomes, we also assessed process indicators, using
standard indicators for quality of care.
Methods
Study design
This was a prospective case-control study, for which data
were collected between November 2015 and April 2016 in
four rural district hospitals. The four districts were purpos-
ively selected based on their performance on a selected set
of key maternal and child health indicators from the na-
tional Health Management Information System (HMIS) in
2013: two of them were good performers (Bugesera and
Rwamagana districts) and two performed poorly (Nyagatare
and Gicumbi) regarding maternal health. The four district
hospitals serve a total population of more than 1.5 million
people (approximately 10% of the country’s total popula-
tion) and in total they have 76 rural health centers in their
catchment areas.
Definition
A woman with a severe maternal outcome (SMO) could
be either a maternal near-miss case or a woman who ac-
tually died [8].
Maternal near-miss (MNM) is defined as ‘a woman
who nearly died, but survived a complication that oc-
curred during pregnancy, childbirth or within 42 days of
termination of pregnancy.’ [7].
Sampling
All cases fulfilling the criteria of severe maternal out-
come during the study period were included in the
study. The WHO criteria adapted in the Haydom study
(listed in the Additional file 1: Table S1) in Tanzania
were applied [14, 15]. Cases were identified by health
providers who were on duty at the time of admission or
who noticed a deterioration in the woman’s condition
during her stay at the hospital. Controls were selected
from in-patient women who had given birth or were ad-
mitted for pregnancy complications and who did not
have a severe maternal outcome within 48 h of the oc-
currence of the case. At least one of the following char-
acteristics similar to the case was used to select the
control: age, parity, gestational age and mode of delivery.
The number of near-miss cases required was estimated
using the sampsi_mcc function in Stata for sample size
calculation [16]. The parameters for the calculation
were: power of 80% at 5% statistical significance level
and odds ratio of 2. The minimum sample size required
was 120 near-miss cases and two controls per case, giv-
ing a total of 240 controls.
Data collection
Relevant data for cases and controls were extracted from
patient medical files (personal characteristics, clinical in-
formation) and entered into a template developed from
the WHO near-miss approach for maternal health guide
[7]. Missing information, if any, was obtained mostly
from the health centre that had referred the case; espe-
cially information about the patient’s arrival time at the
clinic, at what time the ambulance was called and when
it actually arrived, and the medical status of the mother
and the fetus/infant prior to referral. Additionally, data
were collected on maternal and neonatal outcomes and
on particular interventions that had been undertaken to
prevent and/or manage complications (for example use
of oxytocin for the prevention and treatment of postpar-
tum haemorrhage among cases and controls who gave
birth at hospital; use of magnesium sulfate for treatment
of eclampsia; use of antibiotics for prophylaxis and treat-
ment of sepsis). The inclusion criteria were displayed in
the maternity departments of the four hospitals as a re-
minder to health staff who were required to identify
cases and controls. Data collection forms were made
available at the place where patient registers were kept,
in order to facilitate completion by health staff who had
identified patients with SMO.
The head of the maternity served as the focal point for
the study and was trained along with several other staff
from each hospital. He/she was also responsible for col-
lecting any missing information from the health centre
that had referred the patient.
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Every 4 weeks, the principal investigator (FS) visited
the hospitals for verification of the completed forms
with the maternity team: this involved checks on the
correct application of inclusion/exclusion criteria and
checks for completeness and consistency of data. The
forms were reviewed case by case with the respective
hospital teams.
Data analysis
Data were entered into an Excel template and then reviewed
for inconsistencies. Statistical analysis was performed using
SPSS Statistics, version 23 (SPSS Inc. Chicago, Illinois).
Univariate analysis was carried out to characterize the SMO
cases and controls in terms of demographic and clinical var-
iables and the underlying causes. Statistical differences
between SMO cases and controls were compared using chi-
square test. Outcome indicators were calculated as proposed
by WHO [8], using the total number of live births during
the study period and the total number of maternal near-
miss and maternal death in the same period. All descriptive
data, including the identified underlying causes, are reported
both as absolute numbers (n) and frequencies (%).
As for process indicators, the principal researcher in
collaboration with the local maternity team identified
the target population for each of the specific interven-
tions of interest, on the basis of which the proportion of
the target population that actually received the recom-
mended intervention was calculated. High proportions
of women receiving appropriate interventions indicate
better quality of care. Crude (cOR) and adjusted (aOR)
odds ratios (including 95% confidence intervals) were
calculated for predictive factors using logistic regression.
Only factors that were statistically significant in univari-
ate analysis were considered for logistic regression.
Associated factors were also examined for statistical sig-
nificance, using chi-square tests and bivariate logistic
regression. The dependent variable was severe maternal
outcome and the independent factors were the status of
the infant at birth and the duration of admission.
Results
Characteristics of women with SMO and controls
During the 5 months data collection period, 5577 live
births were recorded in the four district hospitals. Out
of these, 214 cases of severe maternal outcomes were
identified, of which 201 maternal near-miss cases and 13
maternal deaths. A total of 428 controls were selected
and included in the study. In total the study population
comprised 642 women.
The comparison of SMO cases and controls shows sta-
tistically significant differences in age, marital status and
profession (Table 1). Seven-and-a-half percent of the
cases were younger than 20 years (3.5% among controls)
and 28.4% older than 35 years (12.6% among controls).
Unmarried and unemployed women are seen more
among the cases than in the control group (15.0% versus
5.6%, and 4.2% versus 0.2%, respectively). The two
groups differ significantly with respect to some clinical
characteristics of pregnancy, such as parity, gravidity,
number of antenatal consultation (ANC) and gestational
age. The proportion of SMO was high among women
who did not attend any ANC (27.4%), and in women
with gestational age less than 36 weeks (21.7% for
<24 weeks and 18.5% for 24–36 weeks). The proportion
of stillbirths among the cases was very high (46.1% ver-
sus 0.5% in the control group). Similarly, cases were ad-
mitted for a longer period (70% for 4 days or more) than
controls (31.7%; figures not shown in the table). There
were no statistically significant differences between the
two groups regarding educational level, medical insur-
ance status, previous abortion, previous caesarean sec-
tion and mode of delivery.
Outcome indicators
The severe maternal outcome incidence ratio was 38.4
per 1000 live births (95% CI 33.4–43.4) and the maternal
near-miss incidence ratio was 36.0 per 1000 live births
(95% CI 31.1–40.9) (Table 2). For every maternal death
there were 15.5 near-miss cases. The hospital-based
MMR was 233 per 100,000 live births (95% CI 110–360),
with a mortality index (MI) of 6.1% (95% CI 2.9–9.3).
Of the 214 SMO cases (near-miss and maternal deaths
combined), 188 (87.9%; CI 83.5–92.3) presented the life-
threatening condition on arrival or within the first 12 h
of hospital admission; 94.1% (CI 90.7–97.5) of these
cases were referred from health centers. Death within
12 h occurred in 9 women (4.8%; 95% CI 1.7–7.9;) of
188 women who were ill on arrival or within 12 h.
Twenty-six women developed life-threatening conditions
in the hospital after 12 h of admission and four of them
(15.4%; 95% CI 1.5–29.3) died. Almost all patients
(97.8%) were referred from a health center: only 2.2% of
women came straight to the district hospital.
Predictive and associated factors
In multivariate logistic regression analysis (Table 3), only
marital status (unmarried; aOR = 3.53; CI 1.43–8.71) and
gestational age (<24 weeks: aOR = 190.15; CI 22.62–
1598.87; and 24–36 weeks: aOR = 167.48; CI 21.94–
1278.32) remained as predictive factors for SMO.
Stillbirth (OR = 181.74; CI 43.47–757.99) and length of
stay at the hospital (OR = 7.86; CI 4.49–13.76) were
strongly associated with severe outcomes.
Underlying causes for SMO and associated case fatality
rates
The leading direct causes of several maternal outcomes, as
shown in Table 4, are postpartum haemorrhage (accounting
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Table 1 Socio-demographic and clinical characteristics of the SMO cases and controls
Cases (%) Controls (%) Total Chi-square P-value
Age
< 20 16 (7.5) 15 (3.5) 31 (4.8) 22.02 0.000
20–35 145 (67.8) 359 (83.9) 504 (78.5)
> 35 53 (28.4) 54 (12.6) 107 (16.7)
Marital statusa (N = 630)
Married 182 (85.0) 402 (94.4) 584 (91.3) 15.49 0.000
Unmarried 32 (15.0) 24 (5.6) 56 (8.8)
Professiona (N = 641)
Farmer 200 (93.5) 423 (99.1) 623 (97.2) 17.92 0.000
Other profession 5 (2.3) 3 (0.7) 8 (1.2)
Unemployed 9 (4.2) 1 (0.2) 10 (1.6)
Education levela (N = 637)
Never been to school 15 (7.1) 21 (4.9) 36 (5.7) 7.36 0.25
Primary education 174 (82.5) 327 (76.8) 501 (78.6)
Secondary and higher 22 (10.4) 78 (18.3) 100 (15.7)
Medical Insurance
No 13 (6.1) 38 (8.9) 51(7.9) 1.53 0.216
Yes 201 (93.9) 390 (91.1) 591 (92.1)
Clinical characteristics
Parity
0 60 (28.0) 179 (41.8) 239 (37.2) 15.18 0.002
1 41 (19.2) 78 (18.2) 119 (18.5)
2 to 4 84 (39.3) 140 (32.7) 224 (34.9)
≥ 5 29 (13.6) 31 (7.2) 60 (9.3)
Gravidity
1 65 (30.4) 181 (42.3) 246 (38.3) 13.25 0.001
2 to 4 105 (49.1) 197 (46.0) 302 (47.0)
≥ 5 44 (20.6) 50 (11.7) 94 (14.6)
Previous C/S
No 152 (71.0) 325 (75.9) 477 (74.3) 1.80 0.18
Yes 62 (29.0) 103 (24.1) 165 (25.7)
Previous abortion
No 204 (95.3) 401 (93.7) 605 (94.2) 0.70 0.402
Yes 10 (4.7) 27 (6.3) 37 (5.8)
ANCa (N = 626)
0 55 (27.4) 44 (10.4) 99 (15.8) 31.91 0.000
1 27 (13.4) 50 (11.8) 77 (12.3)
2 to 3 95 (47.3) 263 (61.9) 358 (57.2)
≥ 4 24 (11.9) 68 (16) 92 (14.7)
Gestational agea (N = 594)
< 24 weeks 40 (21.7) 1 (0.2) 41 (6.9) 179.67 0.000
24–36 weeks 34 (18.5) 1 (0.2) 35 (5.9)
≥ 37 weeks 110 (59.8) 408 (99.5) 518 (87.2)
Outcomes
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for 23.4% of all underlying causes), followed by uterine rup-
ture (22.9%), abortion related complications (16.8%), and
hypertensive disorders (8.9%). Malaria (laboratory con-
firmed) was the leading cause for indirect obstetric causes,
accounting for 13.6% of all underlying causes. The CFR was
high for women with hypertensive disorders (10.5%; CI
3.3–24.3), followed by severe postpartum haemorrhage
(8.0%; CI 0.5–15.5) and malaria (6.9%; CI 2.3–16.1). During
the study period, only one hospital (Rwamagana) had its
own blood bank. Among the 49 cases with uterine rupture,
32 (65.3%) had a previous caesarean section and for 6 cases
(12.2%) hysterectomy was performed.
Previous caesarean sections and anaemia were the two
predominant contributory factors, accounting for 26.9%
and 26.6%, respectively. In 42.1% of SMO cases any con-
tributory factor was identified (not shown in the table).
Health providers used oxytocin as part of active man-
agement of third stage of labor in 94.9% of SMO cases
and controls combined (Table 5). Among those who were
diagnosed with severe PPH (58 cases and controls), about
two-thirds (65.5%) received oxytocin only, while among
the other third, three women received ergometrine and/or
misoprostol in addition to oxytocin; in seven cases re-
moval of retained placenta was performed in combination
with oxytocin; six cases underwent hysterectomy (10.3%).
All severe (pre-) eclampsia cases received an anticon-
vulsant at the hospital, mostly magnesium sulphate
(94.7%). Antibiotics were used for all women with an in-
fection (15 cases) and almost all women who underwent
a caesarean section or laparotomy received prophylactic
antibiotics (98.6%). In total, 171 (80%) women of all
SMO cases required blood transfusion; laparotomy was
performed in 51 cases (23.8%).
Discussion
This is the first prospective multicentre case control
study combining maternal death and maternal near-miss
in Rwandan district hospitals, where geographic access
to emergency obstetric care is more of an issue than in
Kigali capital city [9, 10]. Based on an analysis of SMO
that occurred in four district hospitals, this study
assessed the quality of care provided, using the WHO
criteria adapted to the local context [14, 15].
The hospital based maternal mortality ratio was 233
(CI 110–360) per 100,000 live births. SMO.
and near-miss case ratios were relatively high at 38.4
(CI 33.4–43.4) and 36.0 (CI 31.1–40.9) per 1000 live
births, respectively. Our study found a low mortality
index (6.10) and a high maternal near-miss mortality
ratio (15.5). Oxytocin was used for PPH prevention at
96.5% of all evaluated cases; magnesium sulphate as
anticonvulsants in case of severe pre-eclampsia or
eclampsia at 94.7%; and almost in all cases antibiotics
were used in prophylaxis of sepsis in the event of a cae-
sarean section or laparotomy, and in treatment of puer-
peral sepsis. Severe postpartum haemorrhage (23.4%),
uterine rupture (22.9%), severe complications of abortion
(16.8%), malaria (13.6%) and hypertensive disorders
(8.9%) were the predominant causes of SMO. Case fatal-
ity for hypertensive disorders (eclampsia/pre eclampsia)
was high in our settings at 10.5%. Being unmarried and
developing a complication while gestational age was less
than 36 weeks were identified as predictors for develop-
ing SMO and cases were associated with long stay at the
hospital and stillbirth.
We found a hospital based maternal mortality ratio
which corresponds with the 2015 DHS findings [4] and
estimates in a recent UN report [1] which were 210 and
290 per 100,000 live births respectively. However, severe
maternal outcome and near-miss case ratios were much
higher than those found in a hospital-based study con-
ducted in one of the tertiary hospitals in Kigali and in
Musanze district hospital, which reported, SMO ratios
of 11.0 and 24.8, and MNM ratios of 8 and 21.5 per
Table 1 Socio-demographic and clinical characteristics of the SMO cases and controls (Continued)
Cases (%) Controls (%) Total Chi-square P-value
Baby’s condition at birtha (N = 568)
Alive (501) 76 (53.9) 425 (99.5) 501 (88.2) 212.13 0.000
Still birth (67) 65 (46.1) 2 (0.5) 67 (11.8)
Mode of deliverya (N = 532)
Vaginal delivery (n = 274) 44 (45.8) 230 (53.9) 274 (52.4) 2.03 0.155
Caesarean section (n = 249) 52 (54.2) 197 (46.1) 249 (47.6)
Length of hospital staya (N = 641)
0 to 1 day 17 (8) 140 (32.7) 157 (24.5) 104.97 0.000
2 to 3 days 47 (22.1) 152 (35.5) 199 (31.0)
4 to 7 days 126 (59.2) 132 (30.8) 258 (40.2)
More than 7 days 23 (10.8) 4 (0.9) 27 (4.2)
a Missing information for some cases
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1000 live births, respectively [9, 12]. The near miss
prevalence of our present study falls within the range of
findings reported in the two systematic reviews of near-
miss studies, one for Sub-Saharan Africa and the other
for Africa as a whole, which found prevalence rates ran-
ging from 1.1% to 10.1% and from 0.05 to 15.0%, re-
spectively [17, 18]. Both ratios were high, though,
compared to the WHO multi-country survey on mater-
nal and newborn health, which found SMO and MNM
ratios of 6.2 and 8.6 per 1000 live births respectively for
high MMR countries, and 13.1 and 15.9 per 1000 live
births for very high MMR countries, with overall rates of
Table 2 Maternal outcome indicators in four district hospitals in
Rwanda
Live birthsa 5577
Severe maternal outcome indicators
Women with maternal near-miss (MNM)b 201
Maternal death (MD)c 13
Women with severe maternal outcomes
(SMO)d
214
Overall near-miss indicators
Severe maternal outcome ratio (SMOR)
per 1000 live birthse
38.4 (33.4–43.4)
Maternal near-miss incidence ratio per
1000 live birthsf
36.0 (31.1–40.9)
Maternal near-miss mortality ratiog 15.5
Maternal mortality ratio per 100,000
live birthsh
233 (110–360)
Mortality index (%)i 6.1 (2.9–9.3)
Hospital access indicators
Women with SMO at arrival or within
12 h of hospital arrivalk
188
Proportion of SMO at arrival or within
12 h of hospital arrival (%)l
87.9 (83.5–92.3)
Women with SMO at arrival or within
12 h of hospital arrival and referred
from HCm
177
Proportion of SMO at arrival or within
12 h of hospital arrival referred from
HC (%)n
94.1 (90.7–97.5)
SMO at arrival or within 12 h of hospital
arrival who diedo
9
SMO at arrival or within 12 h of hospital
arrival mortality index (%)p
4.8 (1.7–7.9)
Intra hospital care indicators
Women who developed SMO more than
12 h after hospital arrival (intra hospital SMO)q
26
Intra hospital SMO rate (per 1000 live births)r 4.7 (2.9–6.5)
Women with SMO developed after 12 h of
hospital arrival who dieds
4
Intra hospital mortality index (%)t 15.4 (1.5–29.3)
aLive birth (LB): the complete expulsion or extraction from its mother of a
product of conception, irrespective of the duration of the pregnancy, which,
after such separation, breathes or shows any other evidence of life. Each
product of such a birth is considered live born
bNumber of women with maternal near-miss
cNumber of maternal death
dWomen with severe maternal outcome (SMO) the sum of maternal near-miss
and maternal deaths. d = (b + c)
eSevere maternal outcome ratio (SMOR): the number of women with life
threatening conditions per 1000 live births. e = (d/a)*1000LB
fMNM incidence ratio: the number of maternal near-miss cases per 1000 live
births. [MNM IR =MNM/LB]. f = (b/a)*1000LB
gMaternal near-miss mortality ratio: the proportion between maternal near-miss
cases and maternal deaths. g = (b/c)
hMaternal mortality ratio per 100,000 live births
iCase fatality rate: the number of maternal deaths divided by the number of
women with SMO, expressed as a percentage. i = (c/d)*100
kNumber of women with SMO at arrival or within 12 h of hospital arrival
lProportion SMO at arrival or within 12 h among all SMO: the number of SMO who are
ill on arrival or within 12 h divided by the total number of SMO. l = (k/d)*100
mNumber of women with SMO at arrival or within 12 h of hospital arrival and
referred from HC
nProportion of SMO at arrival or within 12 h coming from other health
facilities: the number of SMO who are ill on arrival or within 12 h and coming
from a health center divided by the total number of SMO at arrival or within
12 h. n = (m/k)*100
oNumber of SMO at arrival or within 12 h of hospital arrival who died
pSMO at arrival or within 12 h mortality index: the maternal deaths within 12 h
after arrival divided by the number of women with SMO who were ill on
arrival or within 12 h, expressed as percentage. p = (o/k)*100
qNumber of Women who developed SMO more than 12 h after hospital arrival
(intra hospital SMO)
r Intra hospital SMO rate (per 1000 live births): the number of women with
SMO who developed these life-threatening conditions after 12 h in the
hospital per 1000 live births. r = (q/a)*1000LB
sNumber of women who developed SMO more than 12 h after hospital arrival
tIntra hospital mortality index: the number of maternal deaths who were not ill
on arrival or within 12 h, divided by the number of women with SMO who
were not ill on arrival or within 12 h, expressed as a percentage. t = (s/q)*100
Table 3 Multivariate analysis of the predictive factors for SMO
crude OR (95%CI) adjusted OR (95%CI)
Age (N = 642)
< 20 2.45 (1.18–5.1) 1.20 (0.37–3.86)
20–35 1 1
> 35 1.47 (0.99–2.15) 1.63 (0.99–2.68)
Marital status (N = 640)
Married 1 1
Unmarried 2.95 (1.69–5.14) 3.53 (1.43–8.71)
Profession (N = 641)
Farmer 1 1
Other profession 3.52 (0.83–14.89) 4.33 (0.69–27.37)
Unimployed 19.04 (2.39–151.28) 0.68 (0.01–47.62)
ANC (N = 626)
0 3.54 (1.92–6.53) 0.51 (0.21–1.21)
1 1.53 (0.79–2.96) 0.48 (0.19–1.13)
2 to 3 1.02 (0.61–1.72) 0.68 (0.39–1.20)
≥ 4 1 1
Gestational age (N = 594)
< 24 weeks 148.36 (20.17–1091.30) 190.15 (22.62–1598.87)
24–36 weeks 126.11 (17.07–931.54) 167.48 (21.94–1278.32)
≥ 37 weeks 1 1
cOR and aOR in bold are statistically significant
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8.3 and 9.9 per 1000 live births, respectively [19].The
high ratios in our study may be explained by the fact
that almost all women who deliver at district hospitals in
Rwanda are referred, either because of high-risk preg-
nancy or complications that have occurred. However,
they indicate a third phase delay [20]: either in making a
diagnosis or deciding to refer the patient; or delays in
the referral process at health centre level. Also, the
threshold of blood transfusion (≥1 unit) used in our
study, as per Haydom criteria, is much lower compared
to the WHO criteria for near-miss (≥5 units), which may
further explain the high ratios [15].
The combination of a low mortality index found in our
study compared to other studies [17, 19] and high mater-
nal near-miss mortality ratios compared to other settings
[9, 12, 21–26], could be attributed, at least in part, by the
frequent use of lifesaving interventions observed in our
study. A high coverage of those interventions alone does
not avoid the occurrence of SMO as shown in our study.
Different studies have highlighted that high coverage of
essential interventions is not sufficient to reduce maternal
morbidity and mortality; they suggest that universal cover-
age of life-saving interventions needs to be matched with
comprehensive emergency care and overall improvements
in the quality of maternal health care [19, 27, 28]. Case fa-
tality for hypertensive disorders in pregnancy and/or
labour was also high in other studies, illustrating that bet-
ter treatment of hypertension and starting induction of
labour as soon as possible is needed to improve health
outcomes [15, 21, 24, 29].
Except for marital status, other studies also identified
age, educational level, parity, booking for ANC and gesta-
tional age as predictive factors for SMO [11, 22, 30, 31];
and stillbirth, long duration of admission, caesarean sec-
tion, assisted vaginal delivery, birth asphyxia and low birth
weight as associated factors [17, 32, 33].
While we used the four predictive characteristics iden-
tified in other studies as criteria for matching, we were
unable to apply them simultaneously [11, 22, 30, 31].
This was due to the time limitation for the selection of
the controls (maximum 48 h). Therefore, we selected
controls that were similar to the cases for at least one of
the four matching criteria; this is a limitation of the
study. Although we did analyse the coverage of life
Table 4 Underlying causes of severe maternal outcomes (near-miss and maternal deaths) and their associated CFR
Direct causes MNM (n = 201) MD (n = 13) Total CFR
Severe postpartum haemorrhage 46 (22.9%) 4 (30.8%) 50 (23.4%) 8.0% (0.5–15.5)
Ruptured uterus 46 (22.9%) 3 (23.1%) 49 (22.9%) 6.1% (0.6–12.8)
Severe complications of abortion 35 (17.4%) 1 (7.7%) 36 (16.8%) 2.9% (2.6–8.4)
Hypertensive disorders 17 (8.5%) 2 (15.4%) 19 (8.9%) 10.5% (3.3–24.3)
Puerperal sepsis 15 (7.5%) 0 15 (7%) 0
Abnormal/ectopic pregnancy 3 (1.5%) 0 3 (1.4%) 0
Severe intrapartum haemorrhage 1 (0.5%) 1 (7.7%) 2 (0.9%) 50%
Antepartum haemorrhage 1 (0.5%) 0 1 (0.5%) 0
Indirect causes
Malaria (laboratory confirmed) 27 (13.4%) 2 (15.4%) 29 (13.6%) 6.9% (2.3–16.1)
Unknown causes of anaemia requiring blood transfusion 10 (5.0%) 0 10 (4.7) 0
Table 5 Adherence to clinical standards for management of
obstetric complications
Use of uterotonics for Prevention of postpartum haemorrhage
Target population women giving birth at DH N1 = 511
a
Oxytocin 485 (94.9%)
Misoprostol 7 (1.4%)
All uterotonics 492 (96.3%)
Treatment of PPH
Target population women severe PPH N2 = 58
Oxytocin 38 (65.5%)
Oxytocin/Removal of retained placenta 7 (12.1%)
Oxytocin/Misoprostol 3 (5.2%)
Misoprostol 1 (1.7%)
Hysterectomy 6 (10.3%)
Use of anticonvulsants
Target population women with severe
(pre-) eclampsia
N3 = 19
Magnesium sulfate 18 (94.7%)
Diazepam 1 (5.3%)
Prevention of caesarean section /laparotomy
related infection
Target population undergoing Caesarean
section/laparotomy
N4 = 300
b
Prophylactic antibiotics 456 (98.6%)
Treatment of sepsis
Target population women with sepsis N5 = 15
Parenteral therapeutic antibiotics 15 (100%)
a511 cases among SMO and controls gave birth at district hospital
b249 cases of caesarean sections (Table 1) plus 51 cases of laparotomy
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saving interventions, we were not able to assess whether
the interventions were implemented appropriately. Also,
we used only SMO cases to determine the relatively
CFRs, instead of all cases with particular obstetrical
complications and this could explain the high rate found
in our study as not all cases fitted the SMO criteria.
Conclusions
Severe maternal outcomes are frequent. The high ratios
of SMO and coverage of life saving interventions call for
improvements in the quality of case management and
follow up of pregnant women in order to reduce mater-
nal morbidity and mortality. PPH, eclampsia and rup-
tured uterus are conditions that need particular
attention as these are major causes of SMO and their
case fatality rates are high.
Unmarried women and women with gestational age
below 36 weeks are more likely to develop an SMO and
this is associated with a longer stay at the hospital and
with stillbirth. Surveillance of near miss events would be a
useful addition to maternal death audits. Ideally, the two
instruments should be integrated into routine monitoring
and surveillance, not necessarily with the intention to
examine all near-miss events, but focused on maternal
conditions that are known to have the highest CFR, espe-
cially PPH, eclampsia and ruptured uterus. Increasing the
coverage of life-saving interventions – such as using oxy-
tocin in the management of third stage of labour, which is
currently a policy in many countries and which is also rec-
ommended by WHO – is appropriate but insufficient.
There is a need for improvement of quality of care at the
level of district hospitals, through improved referral prac-
tices and certain types of infrastructure such as blood
banks; this would go a long way in providing true compre-
hensive emergency obstetric care. Health centres will con-
tinue to refer women with obstetric complications to
district hospitals, and although certain delays are unavoid-
able they should be minimised as much as possible. There
is much to be gained from routine confidential enquiry
into obstetric cases, including near-miss events, so as to
learn from the way they are managed at the various levels
of the referral chain.
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